Skip to main content
roleofbiomarkers1920
Article

Research spotlight interview- the role of biomarkers in drug discovery for neurodegenerative disease

There’s a need to propel and reinvigorate the current state of drug discovery pipeline in tackling pressing neurodegenerative disorders such as Alzheimer’s disease (AD), Lewy body dementia, Parkinson’s disease, frontotemporal dementia (FTD), and other diseases that cause dementia.

Dr. Brigid Ryan, a neuroscientist at the Centre for Brain Research at the University of Auckland, investigates neurodegenerative disease by taking a multidisciplinary approach in defining early biomarkers of dementia.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Research spotlight interview- the role of biomarkers in drug discovery for neurodegenerative disease

Download Article